Loading clinical trials...
Loading clinical trials...
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study
The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Lungenklinik Gauting
Gauting, Bavaria, Germany
University Hospital Regensburg
Regensburg, Bavaria, Germany
Klinikum Bremen-Ost
Bremen, City state Bremen, Germany
Asklepios Klinikum Harburg
Harburg, Hamburg, Germany
University Medicine Göttingen
Göttingen, Lower Saxony, Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Saxony, Germany
Charité Universitätsmedizin Berlin
Berlin, Germany
Lungenklinik Heckeshorn
Berlin, Germany
Kliniken der Stadt Koeln
Cologne, Germany
Florence-Nightingale-Hospital
Düsseldorf, Germany
Start Date
August 1, 2023
Primary Completion Date
December 1, 2027
Completion Date
June 1, 2028
Last Updated
August 22, 2025
198
ESTIMATED participants
TTFields
DEVICE
Lead Sponsor
NovoCure Ltd.
NCT05765084
NCT03710876
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07411144